SLP:NASDAQSimulations Plus, Inc. Analysis
Data as of 2026-09-01 - not real-time
$18.40
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
At $18.40, Simulations Plus, Inc. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. With RSI at 62.6 the momentum picture is approaching overbought, alongside a bearish MACD signal. Price has been bracketed by support at $18.28 and resistance at $18.42.
The shares look overvalued, trading on 46.0 times earnings above a sector average of 30.4. Consensus targets land 6.2% below where the shares trade now. Revenue is growing at 7.5% on a 9.9% profit margin.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 2.7%, a beta of 0.97 and a maximum drawdown of 45.5%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.
The shares look overvalued, trading on 46.0 times earnings above a sector average of 30.4. Consensus targets land 6.2% below where the shares trade now. Revenue is growing at 7.5% on a 9.9% profit margin.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 2.7%, a beta of 0.97 and a maximum drawdown of 45.5%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.
Top Market Events
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRNX, SLP, NCSM, and PASG PR...SLP Shareholder Alert: Robbins LLP is Investigating Allegations that the Officers and Directors of Simulation Plus, Inc.Enid News & Eagle1monJohnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting .
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 16.32
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 46.0 versus sector average of 30.4
- Trading above the 200-day average of 16.32
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 46.0 versus sector average of 30.4
- Analyst targets imply -6.2% versus the current price
- Price-to-book of 2.68
Key Metrics & Analysis
Financial Health
Revenue Growth7.50%
Profit Margin9.88%
P/E Ratio46.0
ROE6.17%
ROA5.48%
Debt/Equity0.35
P/B Ratio2.7
Op. Cash Flow$24.9M
Free Cash Flow$18.4M
Industry P/E30.4
Technical Analysis
TrendBullish
RSI62.6
Support$18.28
Resistance$18.42
MA 20$18.36
MA 50$18.30
MA 200$16.32
MACDBearish
VolumeStable
Fear & Greed Index94.79
Valuation
Fair Value$18.37
Target Price$17.25
Upside/Downside-6.25%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.97
Volatility2.71%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
ZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKWTS
Watts Water Technologies, Inc.
STOCKAMZN
Amazon.com, Inc.
STOCKBLK
BlackRock, Inc.
STOCKUSFD
US Foods Holding Corp.
STOCKUSAC
USA Compression Partners, LP
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.